Tag: rare diseases

Evgeny Kobin, MD, MBA: Advancing Global Therapies with Purpose, Precision, and Patient Impact

I am excited to share a deeper look into my professional journey across global pharmaceutical and biotechnology leadership. Over the past several decades, I have been fortunate to support groundbreaking therapies in oncology, rare diseases, diagnostics, and radiopharmaceuticals, always guided by my commitment to putting patients first. Here is my biography.

Barry Jones: Building Teams, Transforming Markets, Changing Lives

I am grateful for the opportunities I have had across the military, pharmaceutical, biotechnology, and technology sectors, and for the chance to work with extraordinary teams throughout my career. My journey has been guided by the belief that there is a difference between making a living and making a difference, and I remain committed to driving innovation and meaningful change in every role I serve. Here is my biography.

Arup Pramanik: Advancing Global Health Through Strategic Innovation and Evidence-Driven Access

Arup Pramanik is a globally recognized healthcare executive who has spent 25 years transforming how innovation reaches patients. With deep expertise in market access, pricing strategy, and digital health, Arup has led major global initiatives across top pharmaceutical companies including Boehringer Ingelheim, Novartis, and Takeda. Known for uniting science with strategy, he has reshaped commercialization pathways through AI, real-world evidence, and value-based models—delivering outcomes that benefit both enterprise growth and health equity. Now preparing for board roles, Arup brings unmatched global insight, cross-sector leadership, and a bold vision for patient-centered innovation.

Marco Petti: Global Medical Affairs Strategist Driving Innovation Across Therapeutic Frontiers

I'm a global medical affairs leader with over two decades of experience spanning clinical research, regulatory strategy, and pharmaceutical innovation across Latin America and the United States. Throughout my career, I've had the privilege of guiding high-performing teams, launching impactful therapies, and aligning regional execution with global vision—most recently as Head of Medical Affairs for Emerging Therapy Areas at Novo Nordisk. Passionate about advancing patient outcomes and fostering collaborative leadership, I bring a strategic, people-centered approach to everything I do in the healthcare space.

Michael S. Moran: Advancing Medicine with Purpose, Leading Change with Integrity

After nearly three decades of experience across the pharmaceutical and life sciences industries, I’m proud to share my executive biography. From commercial launches to global partnerships, keynote speaking, and team leadership, I’ve been fortunate to work with some incredible people and companies, all driven by a common mission: improving lives through innovative medicine.

Rebecca Simamora: Driving Innovation, Excellence and Growth in Biotech and Pharmaceuticals.

I’m thrilled to share my executive biography, highlighting my experience in driving growth, operational excellence, and innovation within the biotech and pharmaceutical industries. From building startup companies to leading transformative clinical and operational strategies, I’ve had the privilege of contributing to life-changing advancements.